SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-16-009524
Filing Date
2016-04-29
Accepted
2016-04-29 13:00:14
Documents
4
Period of Report
2016-06-20
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_042916.htm DEF 14A 267817
2 GRAPHIC pcard1.jpg GRAPHIC 495477
3 GRAPHIC pcard2.jpg GRAPHIC 58057
4 GRAPHIC signature.jpg GRAPHIC 27841
  Complete submission text file 0001171843-16-009524.txt   1069737
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37347 | Film No.: 161604600
SIC: 2834 Pharmaceutical Preparations